Syrenity App for Depression

Part of paid clinical trials in Bloomington, Indiana.

Sponsor
Indiana University
Study ID
NCT06408025
Status
Enrolling By Invitation

Conditions

  • Depressive Symptoms

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Syrenity App — OTHER
    Currently, the Syrenity App has two active interventions. One is an exposure-based intervention called "Face your fears." Another is an intervention based on behavioral activation called "Get better." The app also provides self-report questionnaires for tracking mood along with psychoeducation on a variety of topics relevant to mental health.

Study Details

The goal of this clinical trial is to learn if the Syrenity mental health app reduces depressive symptoms when compared to a control condition. Secondarily, the trial will provide data on the usability and acceptability of the Syrenity app. The main questions it aims to answer are: Does Syrenity reduce self-reported depressive symptoms compared to a waiting list control? How usable is the Syrenity app?

Key Dates

Start date
May 15, 2024
Status verified
Jul 2025
Primary completion
May 1, 2026
Completion
May 1, 2026

Study Design

Enrollment
300 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Syrenity App
    The Syrenity App is a mental health app that has been designed to help improve mental health and well-being. The content on the app was created using cognitive-behavioral therapy principles. It uses both active and passive interventions. Active interventions are interventions where the user engages with the app in a back and forth dialogue (e.g., a conversation about restructuring unhelpful thoughts). Passive interventions meanwhile consist of text or videos that the user can read or watch and do not require dialogue with the app.
  • No Intervention: Waiting list control
    Those assigned to the waiting list control condition will complete weekly surveys as those assigned to the intervention group but will not have access to the Syrenity platform until after the the 6-week trial period.

Primary Outcome Measure

Patient Health Questionnaire 9 (PHQ-9) [ Time Frame: 6 weeks ]

Locations (1)

FacilityCityStateZIPSite coordinators
Indiana UniversityBloomingtonIndiana47408-

Find similar trials in Bloomington, IN

By research site
Indiana University· Bloomington, IN

Related Studies